Our technologies make better cancer care possible by helping women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is.
Each year 2 million women are diagnosed with breast cancer and most will undergo some form of surgery. We want to make that experience better. That’s why we’re working to improve the global standard of cancer care.
This clear focus has helped us grow from an academic research project into a global company with the belief that our technology can become the new standard of care across the world.
Over 400 hospitals in more than 30 countries have already given 70,000 women access to more precise and less invasive breast cancer treatment thanks to our technologies.
By offering physicians new techniques that are more accurate and provide greater flexibility, patients can avoid unnecessary surgery where possible.
Our aim is to give physicians the best possible tools, so that patients can benefit from more precise, less invasive surgery.
We're creating greater access to a better standard of care. Unlike radioactive treatments, our technology can be accessed by any hospital.
Endomag was founded as Endomagnetics in 2007 out of research conducted at the University College London (UCL) and the University of Houston.
The idea: use magnetics to remove the need for radioactivity when staging breast cancer.